Both drugs produce the same family of effects, because both slow gastric emptying and act on appetite signalling. Gastrointestinal symptoms dominate for both. What differs is the mechanism, tirzepatide acting on two receptor pathways rather than one, and how individual people tolerate each, which varies more between people than between drugs.
A note on the numbers you will see elsewhere. Side effect rates from separate trials cannot be compared directly. The semaglutide and tirzepatide weight management programmes enrolled different populations, used different designs, and were never intended to be set against each other. Articles that rank the two by side effect percentage are producing a comparison the underlying studies do not support.
For how this fits alongside the other effects of these medications, see GLP-1 Side Effects: The Complete Management Guide.
The shared list
Nausea, vomiting, diarrhea, constipation, bloating, sulfur burps and reflux occur with both. So do fatigue, headache and dizziness, which usually trace to intake, hydration or blood sugar rather than the drugs directly.
Both carry the same boxed warning regarding thyroid C-cell tumours, and both list pancreatitis, gallbladder disease and kidney injury from dehydration in their prescribing information.
For practical purposes the safety architecture is closely similar, and the red flags are identical: severe abdominal pain radiating to the back, persistent vomiting, inability to keep fluids down.
Where they genuinely differ
Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on both GLP-1 and GIP receptors, and the second pathway is the real difference between them.
That difference has been discussed in relation to tolerability, with some suggestion the dual mechanism may moderate certain effects. This is an area where mechanism is better understood than outcome, and drawing firm conclusions about which is easier to tolerate goes beyond what the evidence supports.
Approved indications also differ, which matters for coverage more than for side effects.
What actually predicts your experience
More than which molecule you take.
Titration pace. How quickly you escalate influences tolerability substantially, and it is adjustable.
What and how you eat. Portion size, fat content and eating speed change symptom severity across both drugs.
Hydration and intake. Behind most of the fatigue, headache and dizziness on either.
Your own physiology. Some people tolerate one poorly and the other well, and there is no reliable way to predict which in advance.
Switching because of side effects
Reasonable, and sometimes it works. People who struggled on one do sometimes do better on the other.
Two things worth knowing before assuming a switch is the answer. Titration restarts, so you go through the adjustment period again. And your plan may have a preferred agent, which affects whether a switch is straightforward or requires an exception request.
Before switching, ask whether slowing down or stepping back on your current drug has been tried, since that resolves a good proportion of tolerability problems without changing anything else.
Individual variation is larger than any difference between the two, and titration pace predicts your experience more than the molecule, covered in slow titration. For the mechanism itself, tirzepatide versus semaglutide goes further.
Frequently asked questions
Which has fewer side effects?
Not answerable from the available trials, which were not designed for that comparison. Individual variation is larger than any difference between them.
Is tirzepatide gentler because of the second receptor?
The mechanism differs and has been discussed in relation to tolerability. Firm conclusions go beyond current evidence.
If one made me sick, will the other?
Not necessarily. Some people tolerate one considerably better.
Do they have the same warnings?
The serious warnings are closely similar. Check the prescribing information for your specific product, since labelling is product-specific.
Does switching mean starting over?
You generally re-titrate, so expect an adjustment period again.
Should I switch to lose more weight?
That is a different question from side effects, and one for your prescriber based on your response and situation.